$CRH

CRH PUBLIC LTD CO (CRH): Results of Operations and Financial Condition

CRH PUBLIC LTD CO (CRH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2resultsannouncement2026.htm EX-99.1 Document Exhibit 99.1 CRH Reports Second Quarter 2026 Results • Strong quarter driven by good commercial management, favorable underlying demand and contributions from acquisitions • Increases in revenues, profits and margins reflec

Original reporting
Published Jul 30, 2026, 10:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 10:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CRH
Bullish
high confidence
Mentioned
$CRH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CRHBullishHigh
01

Why it matters

Traders can update valuation and positioning based on the newly disclosed Q2 datapoints, the reaffirmed FY26 ranges, and the specific Arcosa acquisition terms and expected close window (Q1 2027).

02

Market read

A combined earnings and capital-allocation update with explicit FY26 guidance ranges and a large, pending acquisition provides a fresh catalyst set for CRH positioning.

03

What to watch

Net debt rose sequentially, and the Arcosa close is contingent on approvals, which can introduce volatility around regulatory headlines.

Relevance 7/10Novelty 9/10Timing: filed pre-market today, with FY26 guidance reaffirmed and Arcosa deal terms disclosed

Background

CRH filed an SEC 8-K (Item 2.02) with Q2 2026 results and an attached earnings release (Exhibit 99.1), including segment commentary, acquisitions/divestitures, and FY26 guidance reaffirmation.

Company-level read

Ticker impact

$CRHBullishHigh confidence
Context

CRH reported Q2 2026 results and reaffirmed FY26 guidance, while also disclosing an $8.5bn all-cash deal to acquire Arcosa.

Expected impact

Likely positive bias for CRH shares on guidance reaffirmation and deal premium expectations, tempered by regulatory/stockholder approval risk.

Evidence & confidence

The filing provides concrete Q2 financials (revenue, net income, Adj. EBITDA, EPS) plus explicit FY26 ranges and a defined Arcosa transaction ($150/share, ~8.5bn enterprise value) with stated closing timing and conditions.

Market effects

Reinforces consolidation and capital rotation in North American aggregates and critical infrastructure materials, potentially supporting sector M&A sentiment.

Highlights demand resilience in CRH’s key North American markets and connected portfolio strategy.

Limited direct global read-through beyond signaling continued M&A appetite and execution in construction materials.

Counterpoint

The acquisition increases leverage and execution risk, and the guidance reaffirmation may already be priced while macro/geopolitical uncertainty persists.

Key entities

  • CRH Public Ltd Co

    Reported Q2 2026 results, reaffirmed FY26 guidance, and disclosed the Arcosa acquisition agreement.

  • Arcosa, Inc.

    Agreed to be acquired by CRH in an all-cash transaction for $150 per share, ~8.5bn enterprise value, expected to close in Q1 2027 subject to approvals.

Related articles

$CRHMed

Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?

CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.

$CRHMedAI 8/10

CRH reports stronger 2Q26 earnings and reaffirms outlook

CRH reported 2Q26 revenues of US$10.8bn, up 6% year over year, and net income up 13% to US$1.5bn. Adjusted EBITDA rose 7% to US$2.6bn, with margins improving. CRH completed three non-core divestments and invested US$1.4bn in 17 acquisitions YTD, and agreed to buy Arcosa for US$8.5bn. It reaffirmed 2026 guidance: net income US$3.9-4.1bn, adjusted EBITDA US$8.1-8.5bn, EPS US$5.60-6.05.

$CRHMedAI 8/10

CRH's second quarter revenues up on pricing and demand

CRH reported Q2 2026 revenues up 6% to $10.8 billion, net income up 13% to $1.5 billion, adjusted EBITDA up 7% to $2.6 billion, and diluted EPS up 14% to $2.21, citing pricing momentum, demand, and acquisitions. The company reaffirmed full-year guidance and completed $1.1 billion of acquisitions and $1.7 billion of net divestiture proceeds.

$CRHHighAI 9/10

CRH to Buy Arcosa, Shares Skid

CRH said it will buy 100% of Arcosa in an all-cash deal for $150 per share, subject to Arcosa shareholder and regulatory approvals. The offer implies a 25% premium to Arcosa’s June 18 60-day VWAP. CRH values Arcosa at about $8.5B enterprise value (11.5x 2026E adj. EBITDA) and expects $175M annual synergies by year three.

$CRHHighAI 9/10

CRH To Acquire Arcosa For $150/share, Arcosa Up In Pre-market

CRH plc agreed to acquire Arcosa, Inc. for $150 per share in cash, valuing Arcosa at about $8.5 billion and implying a 25% premium to its 60-day VWAP as of June 18, according to CRH. CRH expects $175 million in annual run-rate cost synergies by year three and accretion within 12 months after closing, targeted for Q1 2027.